Improved overall survival with axicabtagene ciloleucel vs standard of care in second-line large B-cell lymphoma among the elderly: A subgroup analysis of ZUMA-7 Meeting Abstract
| Authors: | Kersten, M. J.; Farooq, U.; Rapoport, A. P.; Locke, F. L.; Leslie, L. A.; Ghobadi, A.; Miklos, D. B.; Jacobson, C. A.; Munoz, J. L.; Johnston, P. B.; Jaglowski, S. M.; Flinn, I. W.; van Meerten, T.; Perales, M. A.; Vandenberghe, P.; Riedell, P. A.; Dorritie, K.; Szwajcer, D.; Tzachanis, D.; Vardhanabhuti, S.; Du, L.; Filosto, S.; Shahani, S. A.; To, C.; Westin, J. |
| Abstract Title: | Improved overall survival with axicabtagene ciloleucel vs standard of care in second-line large B-cell lymphoma among the elderly: A subgroup analysis of ZUMA-7 |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 1761 |
| Language: | English |
| ACCESSION: | WOS:001159306706232 |
| DOI: | 10.1182/blood-2023-173873 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
